Huadong Medicine Co., Ltd
000963
Peringkat dalam Saham
#2704
Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in... Huadong Medicine Co., Ltd is a leading pharmaceutical enterprise based in China, primarily focused on the creation, production, and distribution of a wide variety of medicinal products. Its extensive product catalog encompasses traditional Chinese patent medicines, immunosuppressive agents, endocrine treatments, digestive system remedies, cancer therapeutics, cardiovascular medications, and antibiotics. The company also supplies medical devices and offers solutions in the field of aesthetic medicine. Noteworthy product lines include gastrointestinal agents and Active Pharmaceutical Ingredients (APIs). Beyond its core pharmaceutical activities, Huadong Medicine is involved in the manufacturing and management of both traditional Chinese and Western raw medicines, prepared formulations, and health supplements. Its operations extend to the wholesale trade of Traditional Chinese Medicine (TCM) ingredients, prepared TCM decoction pieces, and various chemical preparations, complemented by warehousing and logistical services. A significant area of focus for the company is the research, development, manufacturing, and commercialization of aesthetic medicine products. Established in 1993, Huadong Medicine Co., Ltd maintains its corporate headquarters in Hangzhou, China.
Harga Saham
$3.89
Kapitalisasi Pasar
$6.83B
Perubahan (1 hari)
-2.22%
Perubahan (1 tahun)
-30.58%
Negara
CN
Perdagangan Huadong Medicine Co., Ltd (000963)
Kategori
Healthcare
Pendapatan untuk Huadong Medicine Co., Ltd (000963)
Pendapatan pada Jun 2026 TTM: $6.59B
Menurut laporan keuangan terbaru dari Huadong Medicine Co., Ltd, pendapatan saat ini (TTM) adalah $6.59B. Pada tahun 2024, perusahaan menghasilkan pendapatan sebesar $5.74B peningkatan dibandingkan pendapatan pada tahun 2023 yang sebesar $5.74B. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Huadong Medicine Co., Ltd dari 2001 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $6.59B | 5.71% |
| 2025 | $6.23B | 8.57% |
| 2024 | $5.74B | 0.04% |
| 2023 | $5.74B | 4.96% |
| 2022 | $5.47B | 0.54% |
| 2021 | $5.44B | 5.47% |
| 2020 | $5.16B | 1.29% |
| 2019 | $5.09B | 14.19% |
| 2018 | $4.46B | 4.21% |
| 2017 | $4.28B | 17.02% |
| 2016 | $3.66B | 9.25% |
| 2015 | $3.35B | 9.38% |
| 2014 | $3.06B | 10.99% |
| 2013 | $2.76B | 17.88% |
| 2012 | $2.34B | 32.41% |
| 2011 | $1.77B | 29.90% |
| 2010 | $1.36B | 18.60% |
| 2009 | $1.15B | 29.99% |
| 2008 | $881.72M | 32.65% |
| 2007 | $664.70M | 30.76% |
| 2006 | $508.34M | 17.77% |
| 2005 | $431.65M | 23.93% |
| 2004 | $348.31M | 23.94% |
| 2003 | $281.03M | 12.60% |
| 2002 | $249.58M | 9.48% |
| 2001 | $227.97M | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| $29.24B | 343.74% |
JP
|
|
| - | - |
CH
|
|
| $6.61B | 0.34% |
IN
|
